Innovate

Partner with world-class scientific co-founders to identify groundbreaking discoveries that significantly improve patients’ lives

Learn More

Collaborate

As Co-Founding CEO, CBO or President, create and take an active role in building the company

Learn More

Accelerate

Value-add investor that supports its companies to help drive a therapy from lab to patient

Learn More

Longwood Fund creates & invests in science-based companies that develop novel solutions for important medical problems

Longwood hosts semi-annual industry meetings with thought leaders and decision-makers across government, pharma, biotech, and academia.

These meetings provide thought-provoking opportunities to discuss areas of collaboration and access to innovation in order to drive innovation forward and accelerate the translation of discoveries into medicines to help patients. View meeting highlights and testimonials from the Longwood Healthcare Leaders Spring meeting at MIT, co-hosted with Sally Kornbluth (President, MIT), Nobel laureate Phil Sharp (Co-Founder, Biogen & Alnylam), and Bob Langer (Co-Founder, Moderna & Momenta).

For more information, visit www.longwoodhealthcareleaders.com

Testimonials

Hear what leaders in the industry have to say about working with us.

Stefan Oelrich, CEO, Bayer Pharmaceuticals

Stefan Oelrich

CEO, Bayer Pharmaceuticals

“Longwood is one of my most trusted venture funds and Christoph Westphal and his team have proven to be a leading innovative resource for translating groundbreaking science into meaningful applications. Our promising co-investments are a testament to our strong partnership. Longwood also constitutes a first-class network of top players in the Boston Biotech ecosystem that I personally benefit from greatly.”

John Maraganore

John Maraganore

CEO (former), Alnylam
Chair (former), BIO

“My first experiences working with Christoph were during the founding days of Alnylam. Christoph brought the smarts, passion, and zeal needed to launch a company with a bold vision and mission. More recently, as a Longwood advisor, I enjoy seeing the ‘future Alnylams’ Christoph and his team are minting!”

 

Joel Marcus

Executive Chair & Founder
Alexandria Real Estate Equities, Inc. Alexandria Venture Investments

“I have worked with Christoph and the Longwood Fund team since inception and have been thrilled to participate in each of their Funds as well as co-invest and collaborate directly alongside the team on promising deals they source with world-class science. It is also a pleasure to partner on their series of leading industry conferences.”

Bob Langer

Koch Institute Professor, MIT
Co-Founder, Moderna, Momenta

“I’ve known Christoph for over 20 years and worked with him as a founding scientific advisory board member of Alnylam and a founder and a member of the Board of Directors of Momenta. He is a visionary entrepreneur and did an amazing job helping to create both companies.  I’ve also very much enjoyed participating in his terrific conferences.”

Joanne Smith-Farrell

CEO, Be Bio

“From the earliest days of Be Biopharma, Longwood has been a phenomenal partner. The team’s approach to launching the company was exceptionally collaborative, entrepreneurial, and practical – and the groundwork they laid provided a great basis for me to take the reigns when I entered as CEO. We’re building a company that we believe will change countless patients’ lives, and I’m grateful for the partnership.”

Kai Wucherpfennig

Kai Wucherpfennig

Chair, Cancer Immunology & Virology, Dana-Farber; Harvard; Scientific Co-Founder: Immunitas SAB: TScan

“I very much enjoy working with the Longwood team. It has been a fantastic experience to start a biotech company (Immunitas Therapeutics) with Christoph and his team.”